• About Us
    • Our Story
    • Values & Commitment
    • Our Process
    • Meet the Team
    • Our Partners
  • Compliance Services
    • Cell & Gene Therapy
    • Pharmaceutical Drugs
    • Medical Devices
    • FDA 483 / Warning Letter
    • US Agent & Official Correspondent
    • Audits
    • Compliance Without the Attorney Fees
    • Dietary Supplement
    • Facility Registration & Listing
    • FDA Compliance
    • Good Supply Practice
    • Modernization of Cosmetics Regulation Act
    • Quality Culture
    • Product Recalls
    • Quality Systems
    • Regulatory Affairs
    • Training
    • Virtual Quality Assurance
  • Expertise
    • Pharmaceutical
    • Medical Devices
    • Clinical
    • Biologics
  • Resources
    • Compliance Insight Blog
    • GXP Infusion
    • Quality Assurance Accreditation
    • Success Stories
    • Videos and Media
    • White Papers And Downloads
  • Search
  • Contact
Compliance Insight
Skip to content
  • About Us
    • Our Story
    • Values & Commitment
    • Our Process
    • Meet the Team
    • Our Partners
  • Compliance Services
    • Cell & Gene Therapy
    • Pharmaceutical Drugs
    • Medical Devices
    • FDA 483 / Warning Letter
    • US Agent & Official Correspondent
    • Audits
    • Compliance Without the Attorney Fees
    • Dietary Supplement
    • Facility Registration & Listing
    • FDA Compliance
    • Good Supply Practice
    • Modernization of Cosmetics Regulation Act
    • Quality Culture
    • Product Recalls
    • Quality Systems
    • Regulatory Affairs
    • Training
    • Virtual Quality Assurance
  • Expertise
    • Pharmaceutical
    • Medical Devices
    • Clinical
    • Biologics
  • Resources
    • Compliance Insight Blog
    • GXP Infusion
    • Quality Assurance Accreditation
    • Success Stories
    • Videos and Media
    • White Papers And Downloads
  • Search
  • Contact

The FDA has announced the user fee rates for 2020

August 14, 2019by TLM

Share
  • Facebook
  • Twitter
  • LinkedIn
  • Email

 

The FDA has announced the user fee rates for 2020. They include fee rates for prescription drugs, generic drugs, biosimiliars and outsourcing facilities. Click the link below to learn more about the user fee rates for fiscal year 2020.

Learn More about Prescription Drug User Fee Rates for Fiscal Year 2020

Uncategorized

Be in Touch

info@compliance-insight.com
p. 513-860-3512

Corporate Headquarters

497 Circle Freeway Suite 230
Cincinnati, Ohio 45246

Business Hours

Monday – Friday
8:30am EST – 5:30pm EST

Social

© 2025 by Compliance Insight All Rights Reserved | Contact Us

Privacy Policy | Terms of Use | Use of Cookies